Risk Factors for Cisplatin-Induced Nephrotoxicity among Cancer Patients in Bangladesh: A Multicenter Cross-Sectional Study
Abstract
Background: Nephrotoxicity is a common complication of Cisplatin based chemotherapeutics. Several factors are
anticipated to be associated with this outcome.
Objectives: This study aimed to determine the potential risk factors associated with Cisplatin-induced nephrotoxicity
among Cancer patients in Bangladesh.
Materials and Methods: A multicenter cross-sectional study was conducted in tertiary-level hospitals. A total of 87
Cancer patients receiving cisplatin-based chemotherapy were enrolled. Serum creatinine and estimated glomerular
filtration rate (¢GFR) as indicative of nephrotoxicity were measured before and after cach chemotherapy cycle. Statistical
analyses were performed to evaluate the risk factors associated with Cisplatin-induced nephrotoxicity.
Results: Mean age of the patients was 47.0£12.6 years with 54% female and 46% male. Among 87 participants,
nephrotoxicity was observed in 17.2% of patients. The Mann-Whitney U test showed a significant difference in age,
baseline creatinine, and ¢GFR between normal and nephrotoxic groups (p=0.002, 0.001, 0.003 respectively). Binary
logistic regression revealed increased odds of nephrotoxicity with increasing age (Odds Ratio (OR) =1.090, 95% CI:
1.026-1.157, p=0.005), diabetes (OR=8.500, 95% CI: 1.949-37.074, p=0.004), dose of cisplatin (OR=1.043, 95% CI:
1.003-1.085, p=0.037), and baseline eGFR (OR=0.953, 95% CI: 0.922-0.986, p=0.005). Diabetes increased the odds of
nephrotoxicity by 8.5 times than non-diabetic.
Conclusion: Increased age, being diabetic, high baseline creatinine and low baseline eGFR were key risk factors for
nephrotoxicity. Adopting early preventive measures for risk groups may reduce the impact of Cisplatin-induced
nephrotoxicity.
Keywords
Cisplatin
Nephrotoxicity
Cancer
Chemotherapy
Risk factors.
Introduction
Cisplatin is a potent chemotherapeutic agent used for
various solid neoplasia." > It is frequently used as an
adjunct with other chemotherapeutic drugs.’ It exerts
its cytotoxic anticancer properties by interfering with
cellular replication through direct Deoxy-ribonucleic
acid (DNA) damage which leads to defective gene
expression and the production of Reactive oxygen
species (ROS), and eventually cellular damage and death." **3 Despite its potency in Cancer treatment, it
demonstrates multisystem cytotoxic effects like
gastrointestinal toxicity, neurotoxicity, ototoxicity,
marrow suppression, immunological reaction and
notably nephrotoxicity with varying degrees of renal
impairment which limits it use now-a-days. Among all
these side effects of Cisplatin, nephrotoxicity is
considered the most important and complicated because of the complexity of dose modification and
ambiguous risk benefit ratio. Studies revealed that
cisplatin can induce nephrotoxicity in 8-40% of cases.’